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Abstract
A colorimetric sensing strategy employing gold nanoparticles and a paper assay platform has
been developed for tuberculosis diagnosis. Unmodified gold nanoparticles and single-stranded
detection oligonucleotides are used to achieve rapid diagnosis without complicated and
time-consuming thiolated or other surface-modified probe preparation processes. To eliminate
the use of sophisticated equipment for data analysis, the color variance for multiple detection
results was simultaneously collected and concentrated on cellulose paper with the data readout
transmitted for cloud computing via a smartphone. The results show that the 2.6 nM
tuberculosis mycobacterium target sequences extracted from patients can easily be detected,
and the turnaround time after the human DNA is extracted from clinical samples was
approximately 1 h.
Keywords: Tuberculosis diagnostics, microfluidic paper-based analytical devices, colorimetric
assay
1. Introduction
This paper describes a colorimetric sensing strategy
employing unmodified gold nanoparticles (AuNPs) and
microfluidic paper-based analytical devices (µPAD) for
tuberculosis (TB) diagnosis. After mixing with the AuNPs
colloid and then being triggered with sodium chloride
solution, unmodified single-stranded deoxyribonucleic acid
(ssDNA) detection sequences were directly hybridized
with extracted double-stranded DNA (dsDNA) from TB
patients or healthy persons without complicated AuNP probe
preparation processes. The specific IS6110 dsDNA sequence
of Mycobacterium tuberculosis complex (MTBC) was chosen
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as the diagnostic target for recognition [1]. When the
target DNA sequences were absent, the detection ssDNA
sequences were absorbed on the AuNP surfaces and protected
unmodified AuNPs from aggregation in the high salt solution.
The detection ssDNA sequences were hybridized with target
DNA when the target DNA sequences were present, and the
color of the unprotected AuNPs colloid turned from red to
blue [2, 3].
Multiple detection results were simultaneously collected
and concentrated from the paper assay platform. Data was
readout by smartphone and analysis was performed via cloud
computation to avoid the necessity for sophisticated detection
equipment [4–6]. By using the proposed diagnostic platform,
2.6 nM MTBC target sequences could be detected via the
color variance of AuNP spots on paper, and the turnaround
time after human DNA is extracted from clinical samples
could be as little as 1 h.
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TB is a common and often lethal infectious disease
caused by various strains of mycobacteria, usually
M. tuberculosis in humans. Despite encouraging progress in
reducing the mortality and incidence rates of TB, this disease
remains a global public health problem. According to the
World Health Organization (WHO), there were an estimated
8.7 million new cases of TB in the world, and approximately
1.4 million people died from TB in 2011 [7]. In addition,
there has also been a resurgence of the disease worldwide
because of the increase in immunocompromised states caused
by AIDS, chemotherapy regimens or immunosuppressive
therapy.
Skeletal tuberculosis may account for 35% of the
extrapulmonary cases, and TB is often more likely to attack
the spine. If not treated, spinal tuberculosis may cause spinal
deformity or even paraplegia and pulmonary insufficiency.
The clinical presentations of TB and bacterial spine infection
share similarities, and both result in pain due to the loss
of structural integrity. The infection may be confined to the
central body (central pattern) and is often confused with
malignancy. Diagnosing spinal TB is difficult because it is
especially difficult to distinguish between TB infection, other
bacterial infections and spinal tumors using x-ray, computed
tomography (CT) and magnetic resonance imaging (MRI)
assessments [8]. With spinal tuberculosis, therapy is highly
dependent on early correct diagnosis, surgical intervention
and a prolonged multidrug regimen.
Due to the majority of newly infected cases in developing
countries where clinical laboratories and trained personnel for
effective diagnosis and treatment are lacking, a rapid, simple,
low cost and highly accurate on-site detection platform for
spinal TB diagnosis in resource-constrained settings is needed
to achieve early detection of tuberculosis for better patient
management and infection control [9].
After more than a century of diagnostic method
development since the identification of TB in 1882, a
sensitive, rapid and cost-effective diagnostic platform still
remains a challenge. Current TB detection methods mainly
employ sputum smear microscopy, culture of bacilli and
molecular species diagnostics [10–15]. In patients with
TB, a biopsy specimen positive for smear microscopy in
combination with Ziehl–Neelsen staining is a cost-effective
way to obtain the results in minutes in high incidence areas.
However, this identification method has a sensitivity of only
approximately 50% (34–80%), especially in HIV-infected
patients, and additional diagnostic methods need to be used
to confirm negative results [10, 11]. Bacillus culture can
be considered the standard method for TB detection in
a clinical center. However, the result cannot be obtained
instantly based on MTB because the bacillus requires 3–6
weeks for growth on solid culture media and 9–16 days
using rapid liquid culture media [12, 13]. For this reason,
polymerase chain reaction can be used to identify the
mycobacterium with a sensitivity and accuracy of 95 and
92%, respectively. Molecular species diagnostics such as
nucleic acid amplification tests adopt reverse-transcription
polymerase chain reaction (RT-PCR) to amplify the specific
MTB target DNA such as IS6110, 16S rDNA, cyp141, etc.,
from extracted sputum or tissue samples. These analyses
possess the ability to achieve high accuracy, full automation
and simultaneous detection of multiple MTB strains [14,
15]. However, test turnaround time including multiple
hybridization processes requires 2–5 h, and the requirement
of sophisticated infrastructure and trained personnel limits the
feasibility of applying this test in the developing countries.
With the boost of various nanomaterial syntheses in
combination with analytical platforms, AuNPs have been
adopted as versatile biosensors to provide alternative schemes
to conventional detection methods for TB diagnosis [16–19].
AuNPs and different shapes and composition of gold
nanomaterials not only possess a high surface-to-volume
ratio for binding high density biochemical molecules,
they also have specific optophysical and various chemical
characteristics for colorimetric sensing based on controlling
the synthesized size, morphology and surrounding chemical
environment [20–27]. The color of monodisperse AuNPs
colloid (13 nm) is red because of the surface plasmon
resonance (SPR), which is caused by the collective oscillation
of the conduction electrons on the AuNP surfaces [28]. When
the AuNPs aggregate, the decrease of interparticle distance
between AuNPs induce surface plasmon coupling resulting
in a red shift of the absorbance wavelength from 520 to
650 nm and a colloid color change from red to blue [29].
By manipulating electrostatic forces and steric repulsion
between neighboring AuNPs, various colorimetric detection
strategies have been developed for TB nucleic acid sensing.
Soo et al adapted a DNA-mediated AuNP assembly initiated
by Mirkin for identification of MTB and differentiation
of MTB from other members of the MTBC from clinical
sputum samples [16, 30]. Two designed ssDNA sequences
that were complementary to both ends of the target DNA
were modified separately on AuNPs. After hybridization
of the target DNA with the probes, AuNPs probes were
aggregated, and the color of the solution changed from red
to purple. Salt-induced aggregation of AuNP probes for TB
diagnosis was proposed by Baptista et al [17, 19]. AuNPs
were also modified with thiolated detection ssDNA that was
complementary to the target DNA. The presence of positive
samples in the complementary AuNP probes prevented
AuNPs aggregation in the high salt solution. In addition,
a paper-based platform and smartphone were combined for
on-site MTBC sensing [19]. However, the detection methods
above used thiol-modified ssDNA sequences for the formation
of AuNPs probes via Au–S bonding. Fabrication of AuNPs
functionalized with thiolated DNA was not only complicated
and took hours to complete, but also required well-trained
personnel.
Here, we introduce a platform using unmodified AuNPs
with an ssDNA detection probe and µPAD for rapid,
cost-effective and high throughput TB diagnosis.
2. Experimental
2.1. Institutional review board approval
All tissue and human samples used in this report were
approved and issued by the institutional review board (IRB)
from Chang Gung Memorial Hospital.
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2.2. Chemicals
Hydrogen tetrachloroaurate(III) trihydrate was purchased
from Acros Organics (Geel, Belgium). Methanol, 2-propanol,
sodium chloride, tris(hydroxymethyl)aminomethane,
boric acid, ethylenediaminetetraacetic acid, ampicillin,
deoxyribonucleotide triphosphate and trisodium citrate
were ordered from Sigma-Aldrich (St Louis, MO).
Oligonucleotides were synthesized and purified by Bio
Basic Inc. (Bio Basic, Ontario, Canada). The water used in all
experiments was ultrapure water purified in a Milli-Q system
(Millipore, Milford, MA). Q solution, RNase, QIAamp DNA
blood mini kits and HotStar Taq DNA Polymerase were
purchased from Qiagen (Hilden, Germany). High Purity
Viral Nucleic Acid Kit was obtained from Roche Applied
Science (Mannheim, Germany). AxyPrep Maxi Plasmid Kit
was purchased from Axygen Biosciences (Union City, CA).
Novel Juice is ordered from Gene direx Inc. (Las Vegas City,
NV). Whatman Grade 1 Chr cellulose chromatography paper
was obtained from GE Healthcare (Little Chalfont, UK).
2.3. Instrumentation
The PCR amplification was performed in an Applied
Biosystems 2720 Thermal Cycler (Life Technologies, CA,
US). The size and morphology of synthesized AuNPs
were verified by a transmission electron microscope (TEM;
H7100, Hitachi High-Technologies, Tokyo, Japan). A UV–Vis
spectrometer (Cintra 10e, GBC, Victoria, Australia) was used
to obtain the extinction spectra of the AuNPs colloid for
concentration and dispersion/aggregation examination. The
PCR amplification was performed in Applied Biosystems
2720 Thermal Cycler (Life Technologies, Carlsbad, CA,
USA). The AuNPs spots of TB diagnostic results on
chromatography paper were recorded using a smartphone
(butterfly, HTC, Taiwan) under artificial white light without
flash. All the images were then uploaded to a cloud storage
(Dropbox, San Francisco, CA) via internet followed by red,
green and blue (RGB) value analyses using free software
ImageJ (National Institutes of Health, US).
2.4. Preparation of AuNPs
The citrate-capped AuNPs were synthesized according to the
citrate reduction of HAuCl4 [31]. To achieve the reduction,
a 25 ml solution containing 38.8 mM trisodium citrate was
added to 250 ml of a boiled 1 mM HAuCl4 solution. Following
continuous heating for an additional 15 min, the AuNPs
colloid was prepared when the color of the solution changed
from yellow to a deep red. The diameter of synthesized
AuNPs was 13± 1 nm, as confirmed by TEM images. The
prepared concentration of AuNPs colloid for TB diagnosis
was estimated by analyzing the extinction spectra using the
Beer–Lambert Law [32].
2.5. Health control DNA extraction
The whole blood samples were collected from healthy
controls and placed into tubes with EDTA buffer. Genomic
DNA was extracted using QIAamp DNA blood mini kits
(Qiagen, Valencia, USA) according to the manufacturer’s
instructions. The extracted DNA was dissolved in tris-borate
buffer (pH 9.0) to a final concentration of 15 ngµL−1 and
stored at −20 ◦C until further use.
2.6. Construction of 123 bp amplicon of IS6110 target
dsDNA sequence
Luria Bertani (LB) plates containing the standard plasmid
and the 123 bp fragment were obtained from Department
of Laboratory Medicine, Chang Gung Memorial Hospital,
Linkou. The white colonies were selected, then grown in
LB broth containing 50µg ml−1 Ampicilin and incubated in
37 ◦C shaker at 225 rpm overnight. DNA was isolated from the
culture using the AxyPrep Maxi Plasmid Kits and amplified
using HotStar Taq DNA Polymerase to confirm the presence
of the 123 bp fragment. Ten micro liters of DNA template
was used in a 50µl reaction mixture containing 0.6µl of
each 25µM primer, 4µl of 2.5 mM dNTP, 5µl of 5×Q
solution, 5µl of 10× buffer, 0.25µl of 5Uµl−1 HotStar Taq
and 24.55µl of RNase free H2O. The temperature cycling
conditions for PCR amplification were as follows: initial
denaturation at 94 ◦C for 15 min, 35 cycles of 94 ◦C for 1 min,
68 ◦C for 1 min, 72 ◦C for 1 min, and a final extension of
72 ◦C for 10 min. The amplified products were analyzed by gel
electrophoresis in 2% agarose prepared in TBE buffer, added
Novel Juice to loading samples, and visualized on a UV-light
transilluminator.
2.7. Paper-based colorimetric diagnosis of TB
The TB diagnosis was performed using salt-induced
colorimetric development of the AuNPs colloid with analyte
solutions followed by data readout using a paper-based
platform and a smartphone. The hydrophobic barrier was
formed by printing solid wax on the chromatography
paper and then heating to 140 ◦C for 2 min on a hot
plate. Detection oligonucleotide sequences were dissolved
(100 mM) in tris-borate buffer (50µl, pH 9.0) to form
a 1.3 nM probe solution. IS6110 (2.6 nM, 0.52 pmol) and
healthy control DNA sequences (2.6 nM, 0.52 pmol) were
prepared in tris-borate buffer (50µl, pH 9.0) and were then
added to detection oligonucleotide solutions, followed by a
hybridization process that included denaturalization at 90 ◦C
for 1 min and annealing at room temperature for 4 min. A
1 M sodium chloride solution (50µl) was added to the analyte
mixture, and 850µl of 0.5 nM AuNPs colloid was then added.
After 30 min of color development, the mixture was then
pipetted onto the chromatography paper with a solid wax
forming the hydrophobic barriers and color standard for image
analysis.
3. Results and discussion
Based on the SPR effect, the color of the gold colloid may be
correlated to the degree of aggregation of AuNPs in aqueous
solution [33]. The status of the aggregation depends on the
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Figure 1. The schematic illustration of the proposed TB diagnostic. Unknown extracted human DNA sequences were first hybridized with
detection oligonucleotide sequences followed by addition of AuNPs colloid and triggering of the colorimetric sensing with a sodium
chloride solution. If the extracted DNA sequences consisted of IS6110 target sequences, the detection oligonucleotide sequences would
hybridize with them, and only a few ssDNA sequences would be absorbed on the AuNP surface to avoid aggregation after the addition of
salt. In the absence of IS6110 target sequences, the color of the mixture remains red after hybridization and does not change. The mixture
was then spotted, and concentrated on the chromatography paper confined by solid wax hydrophobic barriers. A smartphone was used to
take images of the diagnostic results and transmit to a server for cloud computing.
surface charge and steric effect on the AuNPs surfaces that can
be manipulated by introducing salt into the solution or binding
biomolecules via electrostatic adsorption, high affinity Au–S
or Au–N bonding or control of the medium properties
and composition [34, 35]. In this report, a salt-induced
colorimetric sensing strategy employing unmodified AuNPs
and a paper assay platform for TB diagnosis was adopted. The
schematic illustration of the TB diagnosis combining salt-
induced AuNPs sensing and the µPAD is shown in figure 1.
The detection oligonucleotide sequences were first hybridized
with extracted DNA sequences from patients or healthy
controls from healthy humans, followed by addition to the
AuNPs colloid and induction of colorimetric sensing with
a sodium chloride solution. Unmodified ssDNA sequences
were used to replace the costly thiolated ssDNA as detection
probes, and the complicated preparation procedure for
AuNPs conjugated molecular probes was eliminated to
shorten the diagnosis time. The mixture was then spotted and
concentrated on the chromatography paper confined by solid
wax hydrophobic barriers. A smartphone was used to take
images of the diagnostic results and transmit these images to
a server for cloud computing.
3.1. Colorimetric sensing of TB using unmodified AuNPs and
ssDNA for TB diagnosis
The AuNPs are dispersed in an aqueous solution based on the
interparticle repulsion induced by the negative surface charge
of AuNPs synthesized using the citrate reduction method [36].
When a high salt solution is added, the dissociative ions
shelter the electrostatic repulsion and result in the aggregation
of AuNPs [37]. However, if detection ssDNA sequences are
added to the AuNP colloid before the addition of salt, the
uncoiled ssDNA would absorb on the AuNP surface based
on the hydrophobic interaction [38], exposing the negatively
charged phosphate backbone to avoid aggregation. In contrast,
dsDNA added to the AuNP colloid would not absorb on the
negatively charged AuNPs surfaces because dsDNA possesses
a stable double-helix structure that presents a negatively
charged phosphate backbone, so dsDNA would not prevent
the aggregation of AuNPs in a high salt solution [2, 3].
The different optical properties of the salt-induced AuNPs
aggregation can be adopted for DNA-hybridization-based
biomolecular recognition assays.
In this report, unmodified 13 nm AuNPs were
used, and a 24-mer oligonucleotide sequence,
4
Sci. Technol. Adv. Mater. 14 (2013) 044404 T-T Tsai et al
Figure 2. UV–Vis extinction spectra of unmodified AuNPs-based
TB sensing. (I) The absorbance wavelength of the unmodified
13 nm AuNPs colloid centered at approximately 520 nm. (II) After
addition of 25 mM salt into the AuNPs colloid, the salt induced the
aggregation and the absorbance wavelength of the AuNPs colloid
was red-shifted to ∼610 nm. (III) In the presence of 2.6 nM IS6110
target sequences, most of the detection oligonucleotide sequences
would hybridize with them and would not provide extra negative
charges on the AuNP surfaces to avoid aggregation when 25 mM
salt was added. (IV) In contrast, the healthy control does not contain
IS6110 target sequences, so the 1.3 nM detection ssDNA sequences
would absorb on the AuNP surface to resist aggregation when
25 mM salt is added. The extinction ratio of Ext520/610 increases to
∼2.4 comparing to 1.7 for case (III). The inserted TEM image
shows the diameter of synthesized AuNPs is 13 ± 1 nm.
5′-CTC-CGT-CCA-GCG-CCG-C-3′, which is complemen-
tary to the IS6110 target DNA sequence, was chosen as
the detection ssDNA sequence. The presence of the123 bp
fragment indicates the positive test for the M. tuberculosis
complex, so IS6110 dsDNA was served as the positive target
sequence to verify the proposed colorimetric assay in this
study. When the extracted DNA samples consist of the IS6110
target sequence, detection ssDNA would hybridize with the
target DNA sequence and would not protect the AuNPs from
aggregation after adding a high salt solution. In contrast, the
detection ssDNA sequence would suspend and attach on the
AuNP surface to serve as protection if the test DNA was
extracted from a healthy human.
A moderate amount of 25 mM salt was chosen to be
used in the following tests according to the colorimetric
sensing mechanism. The amount was chosen between a large
amount of salt (>0.2 M) causing AuNP aggregation even
with ssDNA protected and an insufficient amount of salt
(<10 mM) introducing no color variance of the unmodified
AuNPs colloid. The degree of aggregation of the AuNP
mixture was first measured via UV–Vis spectroscopy to verify
the proposed colorimetric sensing mechanism (figure 2). The
absorbance wavelength of the unmodified and monodisperse
AuNP colloid was centered at approximately 520 nm. The
presence of 25 mM salt induced the aggregation of the AuNPs,
and the absorbance wavelength of the AuNP colloid was
red-shifted to ∼610 nm. In the absence of IS6110 target
Figure 3. The colorimetric results of TB diagnosis (a) in cuvettes,
(b) on paper and (c) the analytical values of red/blue of the spots.
The four different solutions are (I) unmodified AuNPs colloid, (II)
AuNPs colloid with 25 mM salt, (III) in the presence and (IV)
absence of 2.6 nM IS6110 target sequences hybridized with
detection ssDNA sequences in AuNPs colloid and then adding
25 mM salt. The colors in the cuvette are (I) red, (II) blue, (III) blue
and (IV) red, and the mean R/B values of the spots on the paper are
approximately 1.12, 0.96, 0.98 and 1.06, respectively (n = 3). The
test conditions are identical to the UV–Vis extinction spectra test of
figure 2 except the volume needed for UV–Vis was 1 ml and the
spotting volume in paper was 200µl.
sequences, ssDNA detection sequences do not hybridize with
healthy human DNA, and they do adsorb on the AuNPs
surface to prevent the aggregation of AuNPs induced by the
addition of salt. If IS6110 target DNA sequences are present,
ssDNA would be hybridized with them, and aggregation of
AuNPs induced by adding salt would result in an increase in
the 520/610 nm extinction ratio to 2.4 compared to 1.7 in the
absence of the IS6110 target sequence.
3.2. Paper assay platform with unmodified AuNPs
colorimetric sensing for TB detection
To achieve on-site TB diagnosis without the use of
sophisticated equipment, a paper assay platform was adopted
for the detection and readout of results (figure 3). A paper
assay platform has several advantages such as low cost,
ease of fabrication, compatibility with biological samples and
compatibility with a wide variety of functionalities, which
make it suitable for resource-constrained settings [4–6]. The
color of the paper is white, so paper is a perfect candidate
for result readout for colorimetric sensing. Solid wax was
printed on the paper and heated to form the hydrophobic
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barriers through the paper cross section so that the AuNP
mixture would be concentrated in the confined circle area and
would reveal the colorimetric results. The amount of the test
mixture used to spot on each paper assay circle was 200µl, an
amount that is smaller than the typical test mixture amount for
UV–Vis spectra, which requires at least 1 ml of test mixture.
Analyzing the AuNP mixture spotted on the paper using a
smartphone and cloud computation, the red-green-blue (RGB)
value red/blue of the spots in the presence of IS6110 target
sequences was <1, and the red/blue value of the spots was
>1 when the test DNA lacks the IS6110 target sequence.
Compared to traditional clinical molecular species diagnostics
that require several hours to finish the tests, the turnaround
time for the proposed platform can be effectively completed
in 1 h after DNA extraction. Thousands of test results can be
analyzed via cloud computing and entered into the database
of the clinical center for disease management and long-term
post-therapy monitoring.
4. Conclusions
TB diagnosis remains challenging because the diagnosis
needs to be sensitive, specific, and (especially) cost-effective
based on the long-term post-treatment monitoring and the
vast numbers of infected individuals in developing countries.
In this report, we utilized salt-induced AuNP colorimetric
diagnosis for sensing target TB DNA sequences without the
need for multiple PCR cycles to amplify specific MTB target
DNA sequences from extracted sputum or tissue samples.
From our results, it is clear that unmodified AuNPs can
be used to avoid complicated and time-consuming AuNP
probe preparation processes, and costly thiolated ssDNA can
be replaced by unmodified ssDNA. In addition, µPAD can
be used for simultaneous screening of multiple results and
analysis to achieve high throughput and to eliminate the
requirement for sophisticated optical detection equipment
and well-trained technicians. We found that, 2.6 nM MTBC
target sequences could be detected, and the diagnosis after
DNA extraction could be completed in 1 h. The ability to
use a smaller amount of sample for testing and a lower
concentration of TB diagnostics can be achieved by using
AuNPs in a catalytic reaction to amplify the colorimetric
signal and more compact paper assay areas. In addition
to using IS6110 for MTBC diagnosis, different series of
target DNA sequences can be adopted to eliminate the cross
interference with other members of the mycobacterium genus
and to further reduce the possibility of false positive or
false negative results. We are still investigating the optimum
parameters for the platform and performing blind tests
using extracted DNA from clinical samples compared to the
bacillus culture results. We believe the proposed platform
possesses the potential for affordable, sensitive, specific,
user-friendly, rapid and robust, equipment-free and highly
end-user-deliverable (ASSURED) diagnostic applications.
Acknowledgments
This work was supported by Chang Gung Memorial Hospital,
Linkou under Grant number CMRPG3G0821 and National
Science Council, Taiwan (NSC 101–2113-M-005–001-MY2).
We thank Pi-Yeih Chang and Mei-Chia Wang from
Department of Laboratory Medicine of Chang Gung
Memorial Hospital, Linkou for providing the standard strain
of M. tuberculosis and technical support. We also thank
Hung-Chen Fang and Natalie Yi-Ju Ho for their assistance in
performing the experiments.
References
[1] Eisenach K D, Cave M D, Bates J H and Crawford J T 1990
J. Infect. Dis. 161 977
[2] Li H X and Rothberg L 2004 Proc. Natl Acad. Sci. USA
101 14036
[3] Li H X and Rothberg L J 2004 J. Am. Chem. Soc. 126 10958
[4] Martinez A W, Phillips S T, Carrilho E, Thomas S W, Sindi H
and Whitesides G M 2008 Anal. Chem. 80 3699
[5] Cheng C M, Martinez A W, Gong J L, Mace C R, Phillips S T,
Carrilho E, Mirica K A and Whitesides G M 2010 Angew.
Chem. Int. Edn Engl. 49 4771
Lo S-J, Yang S-C, Yao D-J, Chen J-H, Tu W-C and
Cheng C-M 2013 Lab Chip 13 2686
Wang H-K, Tsai C-H, Chen K-H, Tang C-T, Leou J-S, Li P-C,
Tang Y-L, Hsieh H-J, Wu H-C and Cheng C-M 2013 Adv.
Healthcare Mater. DOI: 10.1002/adhm.201300150
[6] Martinez A W, Phillips S T, Whitesides G M and Carrilho E
2010 Anal. Chem. 82 3
[7] WHO 2012 Global Tuberculosis Report 2012
[8] Grosskopf I, Bendavid A, Charach G, Hochman I and Pitlik S
1994 Isr. J. Med. Sci. 30 278
[9] Caviedes L, Lee T S, Gilman R H, Sheen P, Spellman E,
Lee E H, Berg D E, Montenegro-James S and Peru T W G
2000 J. Clin. Microbiol. 38 1203
[10] Davies P D O and Pai M 2008 Int. J. Tuberc. Lung Dis.
12 1226
[11] Steingart K R, Ng V, Henry M, Hopewell P C, Ramsay A,
Cunningham J, Urbanczik R, Perkins M D, Aziz M A and
Pai M 2006 Lancet Infect. Dis. 6 664
[12] Lee J J, Suo J, Lin C B, Wang J D, Lin T Y and Tsai Y C 2003
Int. J. Tuberc. Lung Dis. 7 569
[13] Al-Zamel F A 2009 Expert Rev. Anti Infet. Ther. 7 1099
[14] Noordhoek G T et al 1994 J. Clin. Microbiol. 32 277
[15] Yang Y C, Lu P L, Huang S C, Jenh Y S, Jou R and Chang T C
2011 J. Clin. Microbiol. 49 797
[16] Soo P C, Horng Y T, Chang K C, Wang J Y, Hsueh P R,
Chuang C Y, Lu C C and Lai H C 2009 Mol. Cell Probes
23 240
[17] Costa P, Amaro A, Botelho A, Inacio J and Baptista P V 2010
Clin. Microbiol. Infect. 16 1464
[18] Thiruppathiraja C, Kamatchiammal S, Adaikkappan P,
Santhosh D J and Alagar M 2011 Anal. Biochem. 417 73
[19] Veigas B, Jacob J M, Costa M N, Santos D S, Viveiros M,
Inacio J, Martins R, Barquinha P, Fortunato E and
Baptista P V 2012 Lab Chip 12 4802
[20] Daniel M C and Astruc D 2004 Chem. Rev. 104 293
[21] Jain P K, Lee K S, El-Sayed I H and El-Sayed M A 2006
J. Phys. Chem. B 110 7238
[22] Liu C W, Huang C C and Chang H T 2009 Anal. Chem.
81 2383
[23] Hiep H M, Endo T, Kerman K, Chikae M, Kim D K,
Yamamura S, Takamura Y and Tamiya E 2007 Sci. Technol.
Adv. Matter. 8 331
[24] Wang L, Liu C H, Nemoto Y, Fukata N, Wu K C W and
Yamauchi Y 2012 RSC Adv. 2 4608
[25] Yamauchi Y, Wang L, Ataee-Esfahani H, Fukata N, Nagaura T
and Inoue S 2010 J. Nanosci. Nanotechnol. 10 4384
[26] Wang L, Imura M and Yamauchi Y 2012 Crystengcomm
14 7594
6
Sci. Technol. Adv. Mater. 14 (2013) 044404 T-T Tsai et al
[27] Ataee-Esfahani H, Fukata N and Yamauchi Y 2010 Chem.
Lett. 39 372
[28] Thaxton C S, Georganopoulou D G and Mirkin C A 2006 Clin.
Chim. Acta 363 120
[29] Zhao W, Brook M A and Li Y F 2008 Chembiochem 9 2363
[30] Storhoff J J, Elghanian R, Mucic R C, Mirkin C A and
Letsinger R L 1998 J. Am. Chem. Soc. 120 1959
[31] Turkevich J, Stevenson P C and Hillier J 1951 Discuss.
Faraday Soc. 11 55–75
[32] Jin R C, Wu G S, Li Z, Mirkin C A and Schatz G C 2003
J. Am. Chem. Soc. 125 1643
[33] Storhoff J J, Lazarides A A, Mucic R C, Mirkin C A,
Letsinger R L and Schatz G C 2000 J. Am. Chem. Soc.
122 4640
[34] Rosi N L and Mirkin C A 2005 Chem. Rev. 105 1547
[35] Saha K, Agasti S S, Kim C, Li X N and Rotello V M 2012
Chem. Rev. 112 2739
[36] Grabar K C, Freeman R G, Hommer M B and Natan M J 1995
Anal. Chem. 67 735
[37] Hunter R J 2001 Foundations of Colloid Science (Oxford:
Oxford University Press)
[38] Nelson E M and Rothberg L J 2011 Langmuir 27 1770
7
